RICHTER TRANSFORMATION
Clinical trials for RICHTER TRANSFORMATION explained in plain language.
Never miss a new study
Get alerted when new RICHTER TRANSFORMATION trials appear
Sign up with your email to follow new studies for RICHTER TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Target immune cell therapy enters first human trial for tough blood cancers
Disease control ENROLLING_BY_INVITATIONThis is a first-in-human safety study testing a new, experimental CAR-T cell therapy called CAR19.20.22 in adults with B-cell lymphomas that have returned or not responded to at least two prior treatments. The therapy uses the patient's own immune cells, engineered to attack canc…
Matched conditions: RICHTER TRANSFORMATION
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for patients Who've run out of options: experimental drug enters human testing
Disease control OngoingThis early-stage study is testing a new oral drug called BGB-21447 in adults with certain advanced blood cancers that have returned or stopped responding to other treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also loo…
Matched conditions: RICHTER TRANSFORMATION
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC